language_icon
EN
HI

Pfizer Share price

PFIZER

4687.6

97.80 (-2.04%)
NSE
BSE
Last updated on 20 May, 2026 | 15:59 IST
Today's High

4816.20

Today's Low

4656.00

52 Week Low

4388.00

52 Week High

5993.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Pfizer Chart

Pfizer Share Key Metrics

Volume
36554.00
Market Cap
21444.71 CR
LTQ@LTP
27@4687.60
ATP
4688.44
Var Margin
14.03 %
Circuit Range
3828.4-5742.4
Delivery %
51 %
Value
17.14 CR
ASM/GSM
No
Market Lot
1

Summary

Pfizer share price is ₹4687.6 as of 20 May, 2026. The stock Pfizer intraday movement has stayed between ₹4656.00 and ₹4816.20, while on a 52-week basis,Pfizer price 52 week high is ₹5993.00 & its 52 week low is ₹4388.00.
In terms of trading activity, Pfizer has recorded a volume of 36554 shares, The Pfizer has a market cap of ₹45747732 CR. The stock’s Average Traded Price (ATP) stands at ₹4688.44, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 27 @ ₹4687.60.
Pfizer operates within a circuit range of ₹3828.40 – ₹5742.40, with a Value of ₹17.14 CR. The Delivery Percentage for the day is 51%. Additionally, Pfizer currently falls under the No framework, and trades with a market lot size of 1.

Pfizer Fundamentals

View More
P/E Ratio

159.42

P/B Ratio

0

Div. Yield

1.57

Sector P/E

71.7

Sector P/B

3.51

Sec. Div. Yield

0.56

Pfizer Resistance and Support

Pivot 4823.13

Resistance

First Resistance

4886.26

Second Resistance

4987.13

Third Resistance

5050.26

Support

First Support

4722.26

Second Support

4659.13

Third Support

4558.26

Pfizer Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

63.92%

Mutual Fund

11.52%

Insurance

5.31%

Foreign Institutional Investors

2.81%

Domestic Institutional Investors

0.06%

Retail

16.37%

Others

0.01%

Total Promoters
MAR '26
63.92%

Pfizer Corporate Actions

DateAgenda
2026-05-12Audited Results & Final Dividend
2026-02-09Quarterly Results
2025-11-12Quarterly Results
2025-08-13Quarterly Results
2025-05-19Audited Results & Special Dividend
2025-01-31Quarterly Results

Pfizer News

Pfizer Ltd - 500680 - Corporate Action-Board approves Dividend

Pfizer's board recommended a final dividend of ₹75 per share (750%) for the financial year ended March 31, 2026. The Record Date for determining dividend entitlement is July 17, 2026.
May 12 2026 20:05:00

Pfizer Ltd - 500680 - Board Meeting Intimation for Board Meeting To Consider And Approve The Financial Results For The Quarter And Year Ended March 31, 2026.

Pfizer's Board is scheduled to meet on May 12, 2026, to consider and approve the financial results for the fourth quarter and full fiscal year ending March 31, 2026. The meeting will also include discussion on a potential dividend recommendation for the concluded fiscal year.
May 05 2026 22:05:00

Pfizer Limited

Pfizer board will meet on May 12, 2026, to consider its audited standalone yearly financial results for the period ended March 2026. The agenda also includes the recommendation of a final dividend.
May 05 2026 22:05:00

Pfizer Limited

Pfizer board will meet on May 12, 2026, to consider its audited standalone yearly financial results for the period ended March 2026. The agenda also includes the recommendation of a final dividend.
May 05 2026 21:05:00

Pfizer Limited

Pfizer board will meet on May 12, 2026, to consider its audited standalone yearly financial results for the period ended March 2026. The agenda also includes the recommendation of a final dividend.
May 05 2026 21:05:00

US market today: Pfizer posts strong first-quarter, sees boost from recent legal wins

Pfizer reported better-than-expected first-quarter 2026 earnings, with revenues of $14.5 billion and adjusted diluted EPS of $0.75, surpassing analyst estimates. The company reaffirmed its full-year 2026 guidance and demonstrated significant operational revenue growth from launched and acquired products, which largely offset declines in COVID-19 vaccine and treatment sales. Furthermore, Pfizer recently secured a crucial patent extension for its heart drug Vyndamax until 2031 and benefited from a favorable European court ruling regarding COVID-19 vaccine contracts, reinforcing future revenue streams.
May 05 2026 21:05:00

Pfizer among 6 stocks showing bullish RSI upswing

Pfizer's stock has shown a bullish Relative Strength Index (RSI) upswing, indicating strengthening price momentum as its RSI value crossed above 50, according to data from StockEdge.com.
Apr 29 2026 08:04:00
Read More

About Pfizer

NSE : 2643  
BSE : 500680  
ISIN : INE182A01018  

Pfizer Management

NamePosition
Prajeet NairDirector - Corporate Services & Company Secretary
Pradip ShahChairman
View More

Pfizer FAQs

The Buying Price of Pfizer share is 4687.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Pfizer stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Pfizer, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Pfizer shares is 159.42. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Pfizer shares is 0. Useful to assess the stock's value relative to its book value.

To assess Pfizer’s valuation compare Sector P/E, P/B which are 71.7 & 3.51 with sector averages, along with growth rates and financial metrics.

The Market Cap of Pfizer is 21444.71 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Pfizer share price is 5993.00 & 4388.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Pfizer belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost